Steatocystoma multiplex suppurativa (SMS) is a rare and often painful inflammatory variant of steatocystoma multiplex. This condition presents significant diagnostic challenges because it closely mimics hidradenitis suppurativa (HS). Clinicians must identify the presence of sebaceous glands on histopathology to differentiate the two. Once a diagnosis is confirmed, clinicians must implement a targeted Steatocystoma Multiplex Suppurativa treatment plan to manage inflammation and prevent extensive scarring.

Traditional medical management often begins with antibiotics. However, standard therapies like tetracyclines frequently yield inconsistent results. For patients with recalcitrant inflammation, a combination of oral rifampicin and clindamycin has shown promise. Notably, while oral isotretinoin helps some patients by reducing cyst size, it can occasionally trigger severe flares in others. Therefore, doctors must monitor patients closely when initiating retinoid therapy.

Steatocystoma Multiplex Suppurativa treatment with Biologics

Biologic agents represent a modern frontier for severe, inflammatory cases of SMS. Specifically, adalimumab has demonstrated high efficacy in reducing pain and preventing new flares. This anti-TNF agent works by targeting the same inflammatory pathways found in hidradenitis suppurativa. Furthermore, emerging evidence suggests that topical JAK inhibitors, such as tofacitinib, may support long-term remission. These systemic options provide a vital alternative for patients who do not respond to conventional antibiotics.

Surgical intervention remains the most definitive method for cyst removal. Surgeons often prefer minimally invasive techniques like the mini-incision method or CO2 laser ablation. These approaches minimize scarring while effectively clearing the cyst wall. Additionally, for clustered lesions in areas like the axilla, traditional surgical excision may be necessary to prevent recurrence. Ultimately, a multidisciplinary approach combining surgical precision with biologic therapy offers the best hope for patient recovery.

How does Steatocystoma Multiplex Suppurativa differ from Hidradenitis Suppurativa?

While both conditions cause inflammatory nodules in skin folds, SMS arises from sebaceous cysts. Histopathology remains the gold standard for diagnosis. It reveals flattened sebaceous lobules within the cyst wall, a feature that is absent in HS. Furthermore, SMS is often linked to Keratin 17 mutations.

What are the preferred surgical options for SMS?

The most common surgical techniques include needle aspiration, punch excision, and mini-incisions using a No. 11 blade. CO2 lasers are also highly effective because they allow for the treatment of multiple lesions in a single session with excellent cosmetic results.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Vu JT et al. Steatocystoma Multiplex Suppurativa-A Case Report and Review of Treatments. Australas J Dermatol. 2026 Feb 24. doi: 10.1111/ajd.70070. PMID: 41736170.

Atzori L, Zanniello R, Pilloni L, Rongioletti F. Steatocystoma multiplex suppurativa associated with hidradenitis suppurativa successfully treated with adalimumab. J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:42-44. doi: 10.1111/jdv.15848.

Ahmed G, Prabha N, Ganguly S. Familial Steatocystoma Multiplex Generalisita Suppuritiva: Oral Rifampicin and Clindamycin Combination Worth a Trial. Indian J Dermatol. 2021;66(5):553-555. doi: 10.4103/ijd.ijd_371_21.